Quantification of glucosylceramide in plasma of Gaucher disease patients

Muller, Maria Viviane Gomes; Petry, André; Vianna, Luciene Pinheiro; Breier, Ana Carolina; Michelin-Tirelli, Kristiane; Pires, Ricardo Flores; Trindade, Vera Maria Treis; Coelho, Janice Carneiro.
Braz. j. pharm. sci ; 46(4): 643-649, Oct.-Dec. 2010. ilus, graf, tab
Artículo en Inglés | LILACS | ID: lil-622863

Documentos relacionados

  1. Ligand-Controlled Stereoselective Synthesis and Biological Activity of 2-Exomethylene Pseudo-glycoconjugates: Discovery of Mincle-Selective Ligands.
  2. A new method for the preparation of a purified glucosylceramide and ceramide from shiitake mushroom.
  3. Malusides, novel glucosylceramides isolated from apple pomace (Malus domestica).
  4. Direct LC-ESI-MS/MS analysis of plant glucosylceramide and ceramide species with 8E and 8Z isomers of the long chain base.
  5. Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
  6. Liver involvement in Gaucher disease - Review and clinical approach.
  7. [Gaucher's disease].
  8. The structure of complexes between phosphatidylethanolamine and glucosylceramide: a matrix for membrane rafts.
  9. Sphingolipids: Less Enigmatic but Still Many Questions about the Role(s) of Ceramide in the Synthesis/Function of the Ganglioside Class of Glycosphingolipids.
  10. A Simple, High-Throughput Method for Analysis of Ceramide, Glucosylceramide, and Ceramide Trihexoside in Dried Blood Spots by LC/MS/MS.